Amalgamated Bank’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,639
Closed -$20K 1977
2025
Q4
$20K Sell
1,639
-204
-11% -$2.19K ﹤0.01% 2105
2025
Q3
$16K Hold
1,843
﹤0.01% 2230
2025
Q2
$12K Buy
+1,843
New +$10.5K ﹤0.01% 2350
2024
Q2
Sell
-1,764
Closed -$4K 3042
2024
Q1
$4K Sell
1,764
-2,707
-61% -$6.1K ﹤0.01% 2771
2023
Q4
$11K Sell
4,471
-525
-11% -$1.23K ﹤0.01% 2843
2023
Q3
$17K Sell
4,996
-13,640
-73% -$75.6K ﹤0.01% 2724
2023
Q2
$137K Sell
18,636
-567
-3% -$5.26K ﹤0.01% 1963
2023
Q1
$199K Sell
19,203
-606
-3% -$7.33K ﹤0.01% 1806
2022
Q4
$234K Sell
19,809
-1,089
-5% -$16.9K ﹤0.01% 1797
2022
Q3
$439K Buy
20,898
+62
+0.3% +$1.73K ﹤0.01% 1489
2022
Q2
$647K Sell
20,836
-764
-4% -$26.1K 0.01% 1340
2022
Q1
$887K Sell
21,600
-1,098
-5% -$48.4K 0.01% 1261
2021
Q4
$987K Sell
22,698
-9,107
-29% -$412K 0.01% 1232
2021
Q3
$1.59M Sell
31,805
-2,219
-7% -$134K 0.01% 1033
2021
Q2
$2.14M Buy
34,024
+27,206
+399% +$1.75M 0.02% 933
2021
Q1
$633K Sell
6,818
-627
-8% -$64.2K 0.02% 846
2020
Q4
$667K Buy
7,445
+142
+2% +$13K 0.03% 796
2020
Q3
$755K Sell
7,303
-241
-3% -$26K 0.03% 606
2020
Q2
$597K Sell
7,544
-905
-11% -$67.4K 0.03% 719
2020
Q1
$489K Sell
8,449
-161
-2% -$9.28K 0.01% 920
2019
Q4
$465K Buy
8,610
+128
+2% +$6.94K 0.01% 1158
2019
Q3
$443K Sell
8,482
-145
-2% -$6.75K 0.01% 1103
2019
Q2
$417K Buy
8,627
+1,408
+20% +$67.5K 0.01% 1174
2019
Q1
$365K Buy
7,219
+229
+3% +$13.5K 0.01% 1157
2018
Q4
$414K Buy
+6,990
New +$451K 0.01% 1017
2018
Q3
Sell
-7,143
Closed -$361K 1497
2018
Q2
$361K Buy
7,143
+2,335
+49% +$122K 0.01% 1204
2018
Q1
$253K Sell
4,808
-83
-2% -$4.14K 0.01% 1319
2017
Q4
$227K Buy
+4,891
New +$206K 0.01% 1423

Other funds holding EBS